Is insulin resistance: The link between TG-rich lipoproteins and excess death?

Journal of Internal Medicine

Volumn 270, Issue 6, 2011, Pages 600-601

  Reaven, G ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN; TRIACYLGLYCEROL;

BREAST CANCER; CANCER RISK; CARDIOVASCULAR DISEASE; DISEASE ASSOCIATION; HEART INFARCTION; HYPERINSULINEMIA; INSULIN RESISTANCE; LETTER; PRIORITY JOURNAL;

CHOLESTEROL; FEMALE; HUMANS; MALE; MYOCARDIAL INFARCTION; TRIGLYCERIDES;

EID: 81855161629     PISSN: 09546820     EISSN: 13652796     Source Type: Journal    
DOI: 10.1111/j.1365-2796.2011.02460.x     Document Type: Letter

References (28)

1. Nordestgaard BG, Benn M, Schnohr P, Tybjaerg-Hansen A. Nonfasting triglycerides and risk of myocardial infarction, ischemic, and death in men and women. JAMA 2007; 298: 299-308.
2. Langsted A, Freiberg JUJ, Tybjaerg-Hnnsen A, Schnohr P, Jensen GB, Nordestgaard BG. Nonfasting cholesterol and triglycerides and association with risk of myocardial infarction and total morality: the Copenhagen City Heart Study with 31years of follow-up. J Int Med 2011; 270: 65-75.
3. Reaven GM, Lerner RL, Farquhar JW. Stern MP. Role of insulin in endogenous hypertriglyceridemia. J Clin Invest 1967; 46: 1756-67.
4. Olefsky JM, Farquhar JW, Reaven G. Reappraisal of the role of insulin in hypertriglyceridemia. Am J Med 1974; 57: 551-60.
5. Tobey TA, Greenfield MS, Kraemer FB, Reaven GM. Relationship between insulin resistance, insulin secretion, very low density lipoprotein kinetics and plasma triglyceride levels in normotriglyceridemia in man. Metabolism 1981; 30: 165-71.
6. Jeppesen J, Hollenbeck CB, Zhou M-Y et al. Relation between insulin resistance, hyperinsulinemia, postheparin plasma lipoprotein lipase activity, and postprandial lipemia. Arterioscler Thromb Vasc Biol 1995; 15: 320-4.
7. Abbasi F, McLaughlin T, Lamendola C et al. Fasting remnant lipoprotein cholesterol and triglyceride concentrations are elevated in nondiabetic, insulin-resistant, female volunteers. J Clin Endocrinol Metab 1999; 84: 3903-6.
8. Abbasi F, McLaughlin T, Lamendola C et al. High carbohydrate diets, triglyceride-rich lipoproteins, and coronary heart disease risk. Am J Cardiol 2000; 85: 45-8.
9. Masumi A, Tanaka A, Ogita K et al. Relationship between hyperinsulinemia and remnant lipoprotein concentrations in patients with impaired glucose tolerance. J Clin Endocrinol Metab 2000; 85: 3557-60.
10. Kim H-S, Abbasi F, Lamendola C, McLaughlin T, Reaven GM. Effect of insulin resistance on postprandial elevations of remnant lipoprotein concentrations in postmenopausal women. Am J Clin Nutr 2001; 74: 592-5.
11. Sheu WH, Shieh SM, Fuh MM et al. Insulin resistance, glucose intolerance, and hyperinsulinemia. Hypertriglyceridemia versus hypercholesterolemia. Arterioscler Thromb 1993; 13: 367-70.
12. Einhorn D, Reaven GM, Cobin RH et al. American college of endocrinology position statement on the insulin resistant syndrome. Endocr Pract 2003; 9: 237-52.
13. Reaven G. The metabolic syndrome or the insulin resistance syndrome? Different names, different concepts, and different goals. Endocrinol Metab Clin North Am 2004; 33: 283-303.
14. Ginsberg H, Kimmerling G, Olefsky JM, Reaven GM. Demonstration of insulin resistance in untreated adult onset diabetic subjects with fasting hyperglycemia. J Clin Invest 1975; 55: 454-61.
15. Reaven GM. Role of insulin resistance in human disease. Diabetes 1988; 37: 1595-607.
16. Bruning PF, Bonfret JMG, Van Nooyrd PAH, Hart AA, De Jong-Bakker M, Noojen WJ. Insulin resistance and breast cancer risk. Int J Cancer 1992; 52: 511-6.
17. Goodwin PJ, Boyd NF, Hanna W et al. Elevated levels of plasma triglycerides are associated with premenopausal breast cancer risk. Nutr Cancer 1997; 27: 284-92.
18. Goodwin PJ, Ennis M, Pritchard KI et al. Fasting insulin and outcome in early-stage breast cancer: results of a prospective cohort study. J Clin Oncol 2001; 20: 42-51.
19. Goodwin PJ, Ennis M, Baho M et al. High insulin levels in newly diagnosed breast cancer patients reflect underlying insulin resistance and are associated with components of the insulin resistance syndrome. Breast Cancer Res Treat 2009; 114: 517-25.
20. Gunter MJ, Hoover DR, Yu H et al. Insulin, insulin-like growth factor-1, and risk of breast cancer in post-menopausal women. J Natl Cancer Inst 2009; 101: 48-60.
21. Copeland GP, Leinster SJ, Davis JC, Hipkin LJ. Insulin resistance in patients with colorectal cancer. Br J Surg 1987; 74: 1031-5.
22. Hu FB, Manson JE, Hunter D et al. Prospective study of diabetes mellitus (type 2) and risk of colorectal cancer in women. J Natl Cancer Inst 1999; 91: 542-7.
23. Ahmed RL, Schmitz KL, Anderson KE, Rosamond WD, Folsom AR. The metabolic syndrome and risk of incident colorectal cancer. Cancer 2006; 107: 28-36.
24. Giovannuccin E. Metabolic syndrome hyperinsulinemia, and colon cancer: a review. Am J Clin Nutr 2007; 86: 836-42.
25. Currie CJ, Poole CD, Gale EA. The influence of glucose-lowering therapies in cancer risk in type 2 diabetes. Diabetologia 2009; 52: 1766-77.
26. Cannata D, Fierz Y, Archana V, LeRoith D. Type 2 diabetes and cancer: what is the connection? Mt Sinai J Med 2010; 77: 197-213.
27. Reaven GM. Compensatory hyperinsulinemia and the development of an atherogenic lipoprotein profile: the price paid to maintain glucose homeostasis in insulin-resistant individuals. Endocrinol Metab Clin North Am 2005; 34: 49-62.
28. Reaven GM. The insulin resistance syndrome. Curr Atheroscler Rep 2003; 5: 364-71.